Director Zohar Shlomo sold 7,343 shares of Delek US Holdings, Inc. common stock (NASDAQ: DK) on March 19, 2026, according to a Form 4 filed with the Securities and Exchange Commission. The transaction was executed at $46.00 per share for a total value of $337,778.
The disposition occurred close to the stock's 52-week peak of $46.80. At the time of reporting, shares were trading at $42.39, reflecting a 161% gain over the past 12 months.
After completing the sale, Shlomo's direct ownership in the company stands at 6,646 shares. The sale was conducted pursuant to a pre-arranged 10b5-1 trading plan and was signed off by Misty Lavender, Attorney in Fact, on March 23, 2026.
In a separate disclosure of corporate results, Delek US Holdings, Inc. released its financials for the fourth quarter of 2025. The company reported adjusted earnings per share of $2.31, materially above analysts' expectations of -$0.07. That delta has been characterized in filings as a 3,400% positive surprise relative to the consensus estimate.
Despite the strong adjusted EPS print, Delek's quarterly revenue was $2.43 billion, which missed the anticipated $2.55 billion and represented a 4.71% negative surprise versus estimates. The combination of a substantial EPS beat alongside a revenue shortfall presents a mixed set of metrics for market participants to weigh.
Both the insider transaction and the quarterly results have drawn attention from investors. The insider sale was carried out under an established trading plan, and the earnings release highlighted a notable divergence between profitability on an adjusted basis and topline performance.
Given the facts disclosed, market observers will likely continue to monitor company communications and subsequent filings for additional clarification. For now, the record shows an executed 10b5-1 sale by a company director, a sizable adjusted EPS beat in Q4 2025, and a revenue figure that fell short of expectations.
Context summary
- The director sale: 7,343 shares sold at $46.00 on March 19, 2026, totaling $337,778; certified on March 23, 2026.
- Post-sale holdings: Zohar Shlomo directly owns 6,646 shares.
- Q4 2025 results: Adjusted EPS $2.31 vs. -$0.07 expected (3,400% positive surprise); revenue $2.43 billion vs. $2.55 billion expected (4.71% negative surprise).